neomycin sulfate


Also found in: Dictionary, Thesaurus, Encyclopedia.

ne·o·my·cin sul·fate

(nē'ō-mī'sin sŭl'fāt),
The sulfate of an antibacterial antibiotic substance produced by the growth of Streptomyces fradiae, active against a variety of gram-positive and gram-negative bacteria.

neomycin sulfate

[ne′ō-mī′sin]
an aminoglycoside antibiotic.
indications It is prescribed orally to treat hepatic coma and infections of the intestine and to prepare the gastrointestinal tract for surgery. It is prescribed topically to treat skin infections.
contraindications Renal dysfunction, intestinal obstruction, or known hypersensitivity to this drug or to any aminoglycoside medication prohibits its use. Neomycin is not administered parenterally.
adverse effects Among the more serious adverse effects are nausea, vomiting, diarrhea, malabsorption, or superinfection. Prolonged treatment in patients with impaired renal function may result in the toxicities of systemic aminoglycosides (e.g., ototoxicity, nephrotoxicity, neuromuscular toxicity). Hypersensitivity reactions may occur with topical administration of this drug.

ne·o·my·cin sul·fate

(nē'ō-mī'sin sŭl'fāt)
The sulfate of an antibacterial antibiotic substance produced by the growth of Streptomyces fradiae, active against a variety of gram-positive and gram-negative bacteria.

neomycin sulfate

A broad-spectrum antibiotic agent effective against gram-negative and gram-positive organisms, although it is not effective against Pseudomonas aeruginosa. It may be applied topically as eyedrops or eye ointment, but it is most commonly combined with bacitracin and polymyxin B. Syn. framycetin (a mixture of neomycin A, neomycin B and neomycin C).

ne·o·my·cin sul·fate

(nē'ō-mī'sin sŭl'fāt)
Antibacterial antibiotic substance produced by the growth of Streptomyces fradiae, active against gram-positive and gram-negative bacteria.

neomycin sulfate (topical),

n brand name: Myciguent;
drug class: local antibacterial;
action: interferes with bacterial protein synthesis;
use: skin infections.
References in periodicals archive ?
Synergistic responses were observed when ND-497 was used in combination with neomycin sulfate, streptomycin sulfate or polymyxin B sulfate (Table 2).
tetracycline hydrochloride 89 10 [micro]g tetracycline hydrochloride + 10 [micro]g ND-497 71 10 [micro]g ND-497 66 20 [micro]g ND-497 64 20 [micro]g erythromycin 91 10 [micro]g erythromycin + 10 [micro]g ND-497 80 20 [micro]g streptomycin sulfate 70 10 [micro]g streptomycin sulfate + 10 [micro]g ND-497 62 20 [micro]g polymyxin B sulfate 72 10 [micro]g polymyxin B sulfate + 10 [micro]g ND-497 62 20 [micro]g neomycin sulfate 87 10 [micro]g neomycin sulfate + 10 [micro]g ND-497 62
Maleic acid (100 [micro]L), neomycin sulfate (10 [micro]L), and PMSF (5 [micro]L) working solutions were added, and the samples were mixed.
Contract awarded for code: 363 dexamethasone na phosphate o diphosphate with neomycin sulfate solution 0.